Avenue Therapeutics, Inc. (ATXI)
0.385
-0.02
(-4.75%)
USD |
OTCM |
Oct 23, 16:00
Avenue Therapeutics EPS Diluted (Quarterly) : -0.2094 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2094 |
| March 31, 2026 | -0.211 |
| December 31, 2025 | -0.2227 |
| September 30, 2025 | -0.2145 |
| June 30, 2025 | 0.1052 |
| March 31, 2025 | -0.6234 |
| December 31, 2024 | -0.7322 |
| September 30, 2024 | -1.922 |
| June 30, 2024 | -6.429 |
| March 31, 2024 | -7.722 |
| December 31, 2023 | 1.875 |
| September 30, 2023 | 4.862 |
| June 30, 2023 | -38.74 |
| March 31, 2023 | -101.57 |
| December 31, 2022 | 30.67 |
| September 30, 2022 | -33.87 |
| June 30, 2022 | -31.00 |
| March 31, 2022 | -153.58 |
| December 31, 2021 | -55.73 |
| Date | Value |
|---|---|
| September 30, 2021 | -58.93 |
| June 30, 2021 | -64.48 |
| March 31, 2021 | -67.82 |
| December 31, 2020 | -66.70 |
| September 30, 2020 | -70.01 |
| June 30, 2020 | -128.92 |
| March 31, 2020 | -84.81 |
| December 31, 2019 | -365.32 |
| September 30, 2019 | -154.02 |
| June 30, 2019 | -481.46 |
| March 31, 2019 | -922.50 |
| December 31, 2018 | -413.29 |
| September 30, 2018 | -283.54 |
| June 30, 2018 | -506.25 |
| March 31, 2018 | -1158.75 |
| December 31, 2017 | -708.75 |
| September 30, 2017 | -337.50 |
| June 30, 2017 | -787.50 |
| March 31, 2017 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.69M |
| Total Expenses (Quarterly) | 0.69M |
| Enterprise Value | -0.6734M |
| Earnings Yield | -222.8% |
| Normalized Earnings Yield | -222.78 |